Can I use amitriptyline 10 mg for mild insomnia, tension‑type headache, and anxiety?

Amitriptyline 10 mg is NOT recommended as first-line therapy for mild insomnia, but may be considered as a third-line option after preferred treatments have failed, particularly when comorbid anxiety or tension-type headache are present.

For Insomnia

Amitriptyline should not be your first choice for treating mild insomnia. The most recent American Academy of Sleep Medicine guidelines 1 do not include amitriptyline among recommended first-line agents for chronic insomnia. Instead, the recommended sequence is:

First-line options:

• Benzodiazepine receptor agonists (zolpidem, eszopiclone, zaleplon) 1
• Ramelteon (melatonin receptor agonist) 1
• Doxepin (3-6 mg specifically for sleep maintenance) 1

Third-line consideration:

• Sedating antidepressants including amitriptyline are listed as third-line options, specifically when used alongside treating comorbid depression/anxiety 2

Recent evidence on low-dose amitriptyline for insomnia: A 2025 randomized controlled trial 3 found that amitriptyline 10-20 mg produced only a statistically significant but not clinically relevant reduction in insomnia severity at 6 weeks compared to placebo (mean difference -3.4 points on ISI). By 12 weeks, there was no significant difference from placebo. In contrast, mirtazapine showed both statistical and clinical significance.

However, real-world data 4 from 752 patients showed 73.9% reported improved sleep maintenance with low-dose amitriptyline (10-20 mg), though 66.1% experienced at least one side effect.

For Tension-Type Headache

Amitriptyline IS recommended for prevention of chronic tension-type headache. The 2002 guideline 5 specifically recommends amitriptyline 30-150 mg/day as first-line preventive therapy for migraine, and it has established efficacy for tension-type headache prevention 6. However, 10 mg is below the therapeutic range - the FDA label 7 indicates starting doses of 50-100 mg at bedtime for therapeutic effect, with 10 mg three times daily only suggested for adolescent/elderly patients.

A 2016 retrospective study 8 found that low doses (10-25 mg) were commonly used and well-tolerated in headache practice, with 75% of patients reporting improvement, though this was observational data without placebo control.

For Anxiety

Amitriptyline is not a preferred anxiolytic. Guidelines 9 list benzodiazepines (lorazepam, oxazepam) and buspirone as recommended anxiolytics. Amitriptyline is classified as an antidepressant that may help with "associated anxiety" 2 but is not a primary anxiety treatment.

Clinical Algorithm

If your patient has all three symptoms:

1. Start with cognitive behavioral therapy for insomnia (CBT-I) - this is the most effective long-term treatment 2, 10

2. For pharmacologic treatment of insomnia, use:

   • Zolpidem 10 mg, eszopiclone 2-3 mg, or zaleplon 10 mg as first-line 1
   • Reserve amitriptyline for when first-line agents fail OR when comorbid depression/anxiety requires antidepressant treatment

3. For tension-type headache prevention, if frequent enough to warrant prophylaxis:

   • Use amitriptyline at therapeutic doses (starting 25-50 mg at bedtime, titrating to 75-150 mg) 5, 7
   • 10 mg is subtherapeutic for headache prevention

4. For anxiety, consider:

   • Buspirone 5 mg twice daily (for mild-moderate anxiety) 9
   • Or address with CBT/behavioral interventions

Critical Caveats

• The 10 mg dose is problematic: It's subtherapeutic for headache (needs 75-150 mg) 5, 7 and showed minimal benefit for insomnia in the highest-quality recent trial 3

• Side effects at any dose include: daytime sedation (most common at 11% even at low doses 8), dry mouth, constipation, blurred vision, weight gain, and cardiac effects (orthostatic hypotension, QTc prolongation) 7

• Withdrawal symptoms can occur after prolonged use, including rebound insomnia 7

• Avoid in: elderly patients (increased fall risk), cardiac conduction abnormalities, urinary retention, narrow-angle glaucoma 7

Bottom line: If you're committed to using amitriptyline 10 mg for this triad, recognize you're using a suboptimal dose for headache and a third-line agent for insomnia with limited evidence. Consider either increasing to therapeutic doses (25-75 mg) if tolerated, or switching to guideline-concordant first-line agents for each condition.